4//SEC Filing
Toth Christopher A. 4
Accession 0001062993-23-012907
CIK 0000010456other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:03 PM ET
Size
5.5 KB
Accession
0001062993-23-012907
Insider Transaction Report
Form 4
Toth Christopher A.
EVP, Group Pres, Kidney Care
Transactions
- Award
Common Stock, $1 par value
2023-06-01+106,358→ 106,358 total
Footnotes (1)
- [F1]Mr. Toth received a grant of restricted stock units (RSUs)in connection with his appointment as EVP and Group President, Kidney Care. The RSUs are scheduled to vest in three equal annual installments beginning on June 3, 2024, the first anniversary of the grant date, subject to the terms and conditions set forth in the Baxter International Inc. 2021 Equity Plan. However, this award grant will vest in full if (i) by December 31, 2024, the proposed separation of the Kidney Care business (comprised of the Renal Care and Acute Therapies businesses) as a separately traded company (the "Business Transaction") does not occur; or (ii) in connection with the consummation of the Business Transaction, Mr. Toth is not appointed as Chief Executive Officer of the new company, Kidney Co.
Issuer
BAXTER INTERNATIONAL INC
CIK 0000010456
Entity typeother
Related Parties
1- filerCIK 0001753950
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:03 PM ET
- Size
- 5.5 KB